| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 64 |
| 1 | ARIPIPRAZOLE | 53 |
| 2 | PREDNISONE | 33 |
| 3 | ERGOCALCIFEROL | 27 |
| 4 | RISANKIZUMAB-RZAA | 27 |
| 5 | OMEPRAZOLE MAGNESIUM | 25 |
| 6 | INFLIXIMAB | 24 |
| 7 | PANCRELIPASE | 23 |
| 8 | UPADACITINIB | 23 |
| 9 | OMEPRAZOLE | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SINUS WASH | 1 | 0.2500 |
| 1 | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND SODIUM ACETATE ANHYDROUS | 1 | 0.0286 |
| 2 | BABY PETROLEUM JELLY | 1 | 0.0097 |
| 3 | WHITE PETROLATUM JELLY | 1 | 0.0096 |
| 4 | INFLIXIMAB-DYYB | 9 | 0.0026 |
| 5 | PSYLLIUM HUSK | 3 | 0.0022 |
| 6 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 1 | 0.0021 |
| 7 | DROSPIRENONE AND ESTRADIOL | 1 | 0.0019 |
| 8 | ADALIMUMAB-RYVK | 2 | 0.0018 |
| 9 | TEBENTAFUSP | 1 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 72 |
| 1 | Atypical Antipsychotic [EPC] | 67 |
| 2 | Corticosteroid [EPC] | 47 |
| 3 | Interleukin-23 Antagonist [EPC] | 44 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 39 |
| 5 | Proton Pump Inhibitor [EPC] | 37 |
| 6 | Benzodiazepine [EPC] | 34 |
| 7 | Integrin Receptor Antagonist [EPC] | 27 |
| 8 | Provitamin D2 Compound [EPC] | 27 |
| 9 | Endothelin Receptor Antagonist [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 2 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 3 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 4 | Provitamin D2 Compound [EPC] | 27 | 0.0009 |
| 5 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 6 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 7 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 8 | GLP-2 Analog [EPC] | 6 | 0.0004 |
| 9 | Interleukin-23 Antagonist [EPC] | 44 | 0.0004 |